Convention on Psychotropic Substances

Convention on Psychotropic Substances is a United Nations treaty designed to control psychoactive drugs such as amphetamine, barbiturate, benzodiazepine, and hallucinogen among others. The Convention was opened for signature on 21 February 1971 in Vienna and came into force on 16 August 1976.

Background

The Convention was established as a response to the increasing incidence of drug abuse worldwide in the 1960s. The Single Convention on Narcotic Drugs of 1961 did not ban the many newly discovered psychotropics, hence the need for the Convention on Psychotropic Substances. The Convention introduced controls over a number of synthetic drugs according to their abuse potential on the one hand and their therapeutic value on the other.

Provisions

The Convention categorizes the controlled substances into four schedules. Schedule I substances are subject to the highest level of control, while Schedule IV substances are subject to the lowest level of control. The substances are classified based on their potential for abuse and their therapeutic value.

Implementation

The Convention requires parties to take measures to prevent the abuse of psychotropic substances and to ensure that these substances are used for legitimate purposes. This includes legislative and administrative measures, as well as social, educational, and medical measures.

Criticism

The Convention has been criticized for its focus on criminalization and punishment rather than health and human rights. Critics argue that the Convention's approach to drug control is outdated and ineffective.

References

   This article is a law-related stub. You can help WikiMD by expanding it!

   This article is a medical stub. You can help WikiMD by expanding it!